Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT

Joanna Drozd-Sokolowska; Luuk Gras; Linda Koster; Rodrigo Martino; María Queralt Salas; Urpu Salmenniemi; Teresa Zudaire; Lucrecia Yañez; Mar Bellido; Matthew Collin; Martin Kaufmann; Piotr Kozlowski; Xavier Poiré; Christelle Ferra; Antònia Sampol; Keith M O Wilson; Anne Cairoli; Tobias Gedde-Dahl; Eric Deconinck; Milena Mirabile; Felipe Suarez; Kavita Raj; Michel Van Gelder; Ibrahim Yakoub-Agha; Olivier Tournilhac; Donal P McLornan

doi:10.3324/haematol.2023.284359

Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT

Haematologica. 2024 May 1;109(5):1608-1613. doi: 10.3324/haematol.2023.284359.

Authors

Joanna Drozd-Sokolowska¹, Luuk Gras², Linda Koster³, Rodrigo Martino⁴, María Queralt Salas⁵, Urpu Salmenniemi⁶, Teresa Zudaire⁷, Lucrecia Yañez⁸, Mar Bellido⁹, Matthew Collin¹⁰, Martin Kaufmann¹¹, Piotr Kozlowski¹², Xavier Poiré¹³, Christelle Ferra¹⁴, Antònia Sampol¹⁵, Keith M O Wilson¹⁶, Anne Cairoli¹⁷, Tobias Gedde-Dahl¹⁸, Eric Deconinck¹⁹, Milena Mirabile²⁰, Felipe Suarez²¹, Kavita Raj²², Michel Van Gelder²³, Ibrahim Yakoub-Agha²⁴, Olivier Tournilhac²⁵, Donal P McLornan²²

Affiliations

¹ Central Clinical Hospital, The Medical University of Warsaw, Warsaw, Poland;. joanna.drozd-sokolowska@wum.edu.pl.
² EBMT Statistical Unit, Leiden, the Netherlands;. luuk.gras@ebmt.org.
³ EBMT Leiden Study Unit, Leiden, the Netherlands;. cmwpebmt@lumc.nl.
⁴ Hospital Santa Creu i Sant Pau, Barcelona, Spain;. rmartino@santpau.cat.
⁵ Hematology Department (ICHMO). Hospital Clinic de Barcelona, Barcelona, Spain;. mqsalas@clinic.cat.
⁶ Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland;. urpu.salmenniemi@hus.fi.
⁷ Unidad de Ensayos Clínicos de Hematología Pabellón A, bajo., Pamplona, Spain;. teresa.zudaire.ripa@navarra.es.
⁸ Hospital U. Marqués de Valdecilla, Santander, Spain;. lucrecia.yanez@scsalud.es.
⁹ University Medical Center Groningen (UMCG), Groningen, Netherlands;. m.bellido@umcg.nl.
¹⁰ Adult HSCT Unit, Newcastle, United Kingdom;. matthew.collin@ncl.ac.uk.
¹¹ Robert Bosch Krankenhaus, Stuttgart, Germany;. martin.kaufmann@rbk.de.
¹² Örebro University Hospital, Orebro, Sweden;. piotr.kozlowski@regionorebrolan.se.
¹³ Cliniques Universitaires St. Luc, Brussels, Belgium;. xavier.poire@uclouvain.be.
¹⁴ ICO-Hospital Universitari Germans Trias i Pujol, Badalona, Spain;. cferra@iconcologia.net.
¹⁵ Hospital Son Espases, IDISBA, Palma de Mallorca, Balearic Islands, Spain. antonia.sampolm@ssib.es.
¹⁶ University Hospital of Wales, Cardiff, United Kingdom;. keith.wilson@wales.nhs.uk.
¹⁷ Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland;. anne.cairoli@chuv.ch.
¹⁸ Oslo University Hospital, Rikshospitalet, Oslo, Norway;. tgeddeda@ous-hf.no.
¹⁹ Université de Franche-Comté, CHU Besançon, EFS, INSERM, UMR RIGHT, F-25000 Besançon, France;. edeconinck@chu-besancon.fr.
²⁰ Unità Operativa Di Medicina Interna, Civitanove, Italy;. milena.mirabile@hotmail.it.
²¹ Adult hematology, Hôpital Necker-Enfants Malades, AP-HP.Centre Université Paris Cité, Paris, France;. felipe.suarez@aphp.fr.
²² University College London Hospitals NHS Trust, London, United Kingdom;. kavita.raj@nhs.net.
²³ University Hospital Maastricht, Maastricht, Netherlands;. m.van.gelder@mumc.nl.
²⁴ CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000, Lille, France;. ibrahim.yakoubagha@chru-lille.fr.
²⁵ CHU Estaing, Clermont-Ferrand University Hospital, Clermont-Ferrand, France;. otournilhac@chu-clermontferrand.fr.

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Female
Hematopoietic Stem Cell Transplantation* / methods
Humans
Leukemia, Prolymphocytic, T-Cell* / diagnosis
Leukemia, Prolymphocytic, T-Cell* / mortality
Leukemia, Prolymphocytic, T-Cell* / therapy
Male
Middle Aged
Retrospective Studies
Transplantation, Autologous*
Treatment Outcome